{
     "PMID": "26223799",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20180115",
     "LR": "20180129",
     "IS": "1559-1182 (Electronic) 0893-7648 (Linking)",
     "VI": "53",
     "IP": "6",
     "DP": "2016 Aug",
     "TI": "BDNF Induces Striatal-Enriched Protein Tyrosine Phosphatase 61 Degradation Through the Proteasome.",
     "PG": "4261-4273",
     "LID": "10.1007/s12035-015-9335-7 [doi]",
     "AB": "Brain-derived neurotrophic factor (BDNF) promotes synaptic strengthening through the regulation of kinase and phosphatase activity. Conversely, striatal-enriched protein tyrosine phosphatase (STEP) opposes synaptic strengthening through inactivation or internalization of signaling molecules. Here, we investigated whether BDNF regulates STEP levels/activity. BDNF induced a reduction of STEP61 levels in primary cortical neurons, an effect that was prevented by inhibition of tyrosine kinases, phospholipase C gamma, or the ubiquitin-proteasome system (UPS). The levels of pGluN2B(Tyr1472) and pERK1/2(Thr202/Tyr204), two STEP substrates, increased in BDNF-treated cultures, and blockade of the UPS prevented STEP61 degradation and reduced BDNF-induced GluN2B and ERK1/2 phosphorylation. Moreover, brief or sustained cell depolarization reduced STEP61 levels in cortical neurons by different mechanisms. BDNF also promoted UPS-mediated STEP61 degradation in cultured striatal and hippocampal neurons. In contrast, nerve growth factor and neurotrophin-3 had no effect on STEP61 levels. Our results thus indicate that STEP61 degradation is an important event in BDNF-mediated effects.",
     "FAU": [
          "Saavedra, Ana",
          "Puigdellivol, Mar",
          "Tyebji, Shiraz",
          "Kurup, Pradeep",
          "Xu, Jian",
          "Gines, Silvia",
          "Alberch, Jordi",
          "Lombroso, Paul J",
          "Perez-Navarro, Esther"
     ],
     "AU": [
          "Saavedra A",
          "Puigdellivol M",
          "Tyebji S",
          "Kurup P",
          "Xu J",
          "Gines S",
          "Alberch J",
          "Lombroso PJ",
          "Perez-Navarro E"
     ],
     "AD": "Departament de Biologia Cel . lular, Immunologia i Neurociencies, Facultat de Medicina, Universitat de Barcelona, Casanova 143, 08036, Barcelona, Catalonia, Spain. Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain. Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain. Departament de Biologia Cel . lular, Immunologia i Neurociencies, Facultat de Medicina, Universitat de Barcelona, Casanova 143, 08036, Barcelona, Catalonia, Spain. Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain. Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain. Departament de Biologia Cel . lular, Immunologia i Neurociencies, Facultat de Medicina, Universitat de Barcelona, Casanova 143, 08036, Barcelona, Catalonia, Spain. Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain. Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain. Child Study Center, Yale University School of Medicine, 230 South Frontage Road, New Haven, CT, 06520, USA. Child Study Center, Yale University School of Medicine, 230 South Frontage Road, New Haven, CT, 06520, USA. Departament de Biologia Cel . lular, Immunologia i Neurociencies, Facultat de Medicina, Universitat de Barcelona, Casanova 143, 08036, Barcelona, Catalonia, Spain. Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain. Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain. Departament de Biologia Cel . lular, Immunologia i Neurociencies, Facultat de Medicina, Universitat de Barcelona, Casanova 143, 08036, Barcelona, Catalonia, Spain. Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain. Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain. Child Study Center, Yale University School of Medicine, 230 South Frontage Road, New Haven, CT, 06520, USA. Departament de Biologia Cel . lular, Immunologia i Neurociencies, Facultat de Medicina, Universitat de Barcelona, Casanova 143, 08036, Barcelona, Catalonia, Spain. estherperez@ub.edu. Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain. estherperez@ub.edu. Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain. estherperez@ub.edu.",
     "LA": [
          "eng"
     ],
     "GR": [
          "R01 GM054051/GM/NIGMS NIH HHS/United States",
          "R01 MH052711/MH/NIMH NIH HHS/United States",
          "R01 MH091037/MH/NIMH NIH HHS/United States",
          "UL1 TR001863/TR/NCATS NIH HHS/United States"
     ],
     "PT": [
          "Journal Article",
          "Research Support, N.I.H., Extramural",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20150730",
     "PL": "United States",
     "TA": "Mol Neurobiol",
     "JT": "Molecular neurobiology",
     "JID": "8900963",
     "RN": [
          "0 (Brain-Derived Neurotrophic Factor)",
          "0 (NR2B NMDA receptor)",
          "0 (Neurotrophin 3)",
          "0 (Receptors, N-Methyl-D-Aspartate)",
          "9061-61-4 (Nerve Growth Factor)",
          "EC 2.7.11.24 (Extracellular Signal-Regulated MAP Kinases)",
          "EC 3.1.3.48 (Protein Tyrosine Phosphatases, Non-Receptor)",
          "EC 3.1.3.48 (Ptpn5 protein, mouse)",
          "EC 3.1.4.3 (Phospholipase C gamma)",
          "EC 3.4.25.1 (Proteasome Endopeptidase Complex)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Brain-Derived Neurotrophic Factor/*pharmacology",
          "Cerebral Cortex/cytology",
          "Extracellular Signal-Regulated MAP Kinases/metabolism",
          "Hippocampus/cytology",
          "Membrane Potentials/drug effects",
          "Mice",
          "Neostriatum/metabolism",
          "Nerve Growth Factor/pharmacology",
          "Neurons/metabolism",
          "Neurotrophin 3/pharmacology",
          "Phospholipase C gamma/metabolism",
          "Phosphorylation/drug effects",
          "Proteasome Endopeptidase Complex/*metabolism",
          "Protein Tyrosine Phosphatases, Non-Receptor/*metabolism",
          "Proteolysis/*drug effects",
          "Receptors, N-Methyl-D-Aspartate/metabolism",
          "Ubiquitination/drug effects"
     ],
     "PMC": "PMC4738169",
     "MID": [
          "NIHMS754502"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "*Depolarization",
          "*ERK1/2",
          "*GluN2B",
          "*NGF",
          "*NT-3",
          "*PLCgamma",
          "*STEP33"
     ],
     "EDAT": "2015/08/01 06:00",
     "MHDA": "2018/01/16 06:00",
     "CRDT": [
          "2015/07/31 06:00"
     ],
     "PHST": [
          "2015/01/23 00:00 [received]",
          "2015/07/01 00:00 [accepted]",
          "2015/07/31 06:00 [entrez]",
          "2015/08/01 06:00 [pubmed]",
          "2018/01/16 06:00 [medline]"
     ],
     "AID": [
          "10.1007/s12035-015-9335-7 [doi]",
          "10.1007/s12035-015-9335-7 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Mol Neurobiol. 2016 Aug;53(6):4261-4273. doi: 10.1007/s12035-015-9335-7. Epub 2015 Jul 30.",
     "term": "hippocampus"
}